Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: A randomized phase III trial of the Gynecologic Oncology Group

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Clinical Oncology

• Publication date

  2003-12-01

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Predictive value of the surgical Apgar score on postoperative complications in advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by radical gastrectomy: a single-center retrospective study

  2020cites this paper
• Cytoreductive Surgery for Peritoneal Carcinomatosis from Endometrial Cancer – A Case Report and Literature Review

  2015cites this paper
• Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases

  2013cites this paper
• Sequential Adjuvant Chemotherapy and Radiotherapy in Treatment of Early Stage Endometrial Carcinoma: Single Institutional Experience

  2012cites this paper
• Technical Aspects of Radiation Therapy in Endometrial Carcinoma

  2011influential citation
• Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms)

  2011cites this paper
• Advanced age is a significant determinant of poor prognosis in patients treated with surgery plus postoperative radiotherapy for endometrial cancer

  2010cites this paper
• Cáncer de endometrio

  2009cites this paper
• Treatment of Advanced and Recurrent Carcinoma: Chemotherapy

  2009cites this paper
• Significance of concurrent endometrial cancer in women with a preoperative diagnosis of atypical endometrial hyperplasia.

  2008cites this paper
• Cancers gynécologiques

  2008cites this paper
• Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

  2008cites this paper
• Uterine papillary serous carcinoma: a review

  2007cites this paper
• Systemic chemotherapy for uterine carcinoma: metastatic and adjuvant.

  2007cites this paper
• A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study.

  2007cites this paper
• Efficacy and prognostic implications of administering adjuvant chemotherapy to patients with endometrial cancer that is confined to the uterus.

  2007cites this paper
• Treatment modalities in endometrial cancer

  2007cites this paper
• Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration.

  2007cites this paper
• Endometrial Cancer and its Management

  2007cites this paper
• Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes.

  2007cites this paper
• Phase I trial of paclitaxel, doxorubicin, and carboplatin (TAC) for the treatment of endometrial cancer

  2006cites this paper
• Unresolved issues in the chemotherapeutic management of gynecologic malignancies.

  2006cites this paper
• Radiation therapy for gynecologic malignancies.

  2006cites this paper
• Effectiveness of postoperative chemotherapy for para-aortic lymph node metastasis of endometrial cancer.

  2006cites this paper
• Current management of ovarian carcinosarcoma

  2006cites this paper
• Systematic review of systemic therapy for advanced or recurrent endometrial cancer.

  2006cites this paper
• Chemotherapy in endometrial cancer.

  2006cites this paper
• Paclitaxel and concomitant radiotherapy in high-risk endometrial cancer patients: preliminary findings

  2006cites this paper
• Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.

  2006cites this paper
• Der Stellenwert der Chemotherapie in der Therapie des Endometriumkarzinoms

  2006cites this paper
• Treatment of uterine papillary serous carcinoma with platinum‐based chemotherapy and paclitaxel

  2006cites this paper
• Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

  2006cites this paper
• Clinical trials in gynecological cancer

  2006cites this paper
• High-risk surgical stage 1 endometrial cancer: analysis of treatment outcome

  2006cites this paper
• An overview of uterine cancer and its management

  2006cites this paper
• The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.

  2006cites this paper
• Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment

  2006cites this paper
• CONTROVERSIES IN THE MANAGEMENT OF ATYPICAL HYPERPLASIA: CONSERVATIVE MANAGEMENT VS. SIMPLE HYSTERECTOMY

  2005cites this paper
• The Reproducibility of a Binary Tumor Grading System for Uterine Endometrial Endometrioid Carcinoma, Compared with FIGO System and Nuclear Grading

  2005cites this paper
• Adjuvant radiotherapy in endometrial carcinoma.

  2005cites this paper
• Rare uterine cancers.

  2005cites this paper
• Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United States.

  2005cites this paper
• What's new in systemic therapy for endometrial cancer

  2005cites this paper
• Utility and limitations of abdominal radiotherapy in the management of endometrial carcinomas.

  2005cites this paper
• Papillary serous carcinoma--a less radio-sensitive subtype of endometrial cancer.

  2005cites this paper
• A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.

  2005cites this paper
• Resection of lymph node metastases influences survival in stage IIIC endometrial cancer.

  2005cites this paper
• Maligne epitheliale Tumoren des Corpus uteri

  2005cites this paper
• ROLE OF GENE EXPRESSION PROFILING IN DISTINGUISHING BIOLOGICALLY AND CLINICALLY DISTINCT SUBCLASSES OF ENDOMETRIAL CARCINOMA: 0009

  2005cites this paper
• MSI IN ENDOMETRIAL CANCER: PREVALENCE AND CLINICAL APPLICATIONS

  2005cites this paper
• The problem of "lumping versus splitting".

  2005cites this paper
• The role of radiotherapy in the treatment of endometrial carcinoma

  2005cites this paper
• LAPAROSCOPICALLY ASSISTED SURGICAL STAGING FOR ENDOMETRIAL CANCER: 0016

  2005cites this paper
• Future challenges in clinical and translational research for endometrial cancer

  2005cites this paper
• NOVEL STRATEGIES FOR THE MANAGEMENT OF UTERINE MALIGNANT MIXED MULLERIAN TUMORS: 0012

  2005cites this paper
• ROLE OF RADIATION TREATMENT IN INTERMEDIATE RISK ENDOMETRIAL CANCER—CON: 0019

  2005cites this paper
• Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.

  2005cites this paper
• Future Developments in Radiation Therapy for Endometrial Carcinoma

  2005cites this paper
• Combined Therapy in Uterine Cancer: Future Directions

  2005cites this paper
• EARLY MOLECULAR CHANGES IN ENDOMETRIAL CANCER: 0001

  2005cites this paper
• CpG ISLAND METHYLATION PATTERNS IN VARIOUS HISTOTYPES OF ENDOMETRIAL CANCER: 0011

  2005cites this paper
• LOSS OF CABLES IS ASSOCIATED WITH DEVELOPMENT OF ENDOMETRIAL HYPERPLASIA AND CANCER: 0002

  2005cites this paper
• High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.

  2004cites this paper
• The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma.

  2004cites this paper
• Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.

  2004cites this paper
• Endometrial cancer: The management of high-risk disease

  2004cites this paper
• Standards und neue Trends im Management des Endometriumkarzinoms

  2004cites this paper
• Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients.

  2004cites this paper
• Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.

  2004cites this paper
• Clinical Analysis of Recurrent and Advanced Staged Endometrial Cancer

  2004cites this paper
• Brain metastases from endometrial carcinoma: a retrospective study.

  2004cites this paper
• The controversies surrounding the management of uterine serous carcinoma

  2004cites this paper
• Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.

  2004cites this paper
• Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.

  2004cites this paper
• Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.

  2004cites this paper
• Sensitivity to cisplatin determined by the histoculture drug response assay and clinical response of endometrial cancer

  2004cites this paper
• Management des Endometriumkarzinoms

  2004cites this paper
• Endometrial cancer: a frequent orphan disease.

  2004cites this paper
• Endometrial Cancer

  2003cites this paper
• Uterine serous carcinoma: a comparison of therapy for advanced-stage disease

  2003cites this paper
• Strahlentherapie des Endometriumkarzinom

  2003cites this paper
• Chemotherapie des Endometriumkarzinoms

  2003cites this paper